Skip to main content

Altimmune, Inc.

ALT
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001326190

In the last 90 days, Altimmune, Inc. insiders filed 1 open-market purchase and 0 sales; 210 institutions reported holding it in 13F filings for Q2 2026, worth $456.1M in total; Viking Global Investors is the only superinvestor holding it.

13F holders, Q2 2025

Institutional positions in Altimmune, Inc. as of Jun 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
180
+4 vs. Q1 2025
Shares held
37.6M
−579.0K (−1.5%) vs. Q1 2025
Total value
$145.5M
−$45.7M (−23.9%) vs. Q1 2025
New holders
38
72 more added
Sold out
34
39 more reduced

1 institution that held it in Q1 2025 haven't filed for Q2 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2025: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ALT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2025: 180 institutions
Q1 2021: 98 institutionsQ2 2021: 109 institutionsQ3 2021: 119 institutionsQ4 2021: 102 institutionsQ1 2022: 103 institutionsQ2 2022: 111 institutionsQ3 2022: 122 institutionsQ4 2022: 128 institutionsQ1 2023: 133 institutionsQ2 2023: 120 institutionsQ3 2023: 113 institutionsQ4 2023: 143 institutionsQ1 2024: 171 institutionsQ2 2024: 173 institutionsQ3 2024: 169 institutionsQ4 2024: 183 institutionsQ1 2025: 177 institutionsQ2 2025: 180 institutionsQ3 2025: 159 institutionsQ4 2025: 183 institutionsQ1 2026: 173 institutionsQ2 2026: 210 institutions
Value heldQ2 2025: $145.5M
Q1 2021: $336.5MQ2 2021: $269.2MQ3 2021: $375.3MQ4 2021: $295.8MQ1 2022: $207.4MQ2 2022: $466.9MQ3 2022: $588.1MQ4 2022: $769.9MQ1 2023: $205.4MQ2 2023: $124.5MQ3 2023: $79.2MQ4 2023: $377.1MQ1 2024: $452.2MQ2 2024: $282.1MQ3 2024: $243.0MQ4 2024: $292.3MQ1 2025: $191.2MQ2 2025: $145.5MQ3 2025: $156.4MQ4 2025: $198.8MQ1 2026: $213.5MQ2 2026: $456.1M
Institutions holding ALT and their total value by quarter
QuarterHoldersValue
Q2 2026210$456.1M
Q1 2026173$213.5M
Q4 2025183$198.8M
Q3 2025159$156.4M
Q2 2025180$145.5M
Q1 2025177$191.2M
Q4 2024183$292.3M
Q3 2024169$243.0M
Q2 2024173$282.1M
Q1 2024171$452.2M
Q4 2023143$377.1M
Q3 2023113$79.2M
Q2 2023120$124.5M
Q1 2023133$205.4M
Q4 2022128$769.9M
Q3 2022122$588.1M
Q2 2022111$466.9M
Q1 2022103$207.4M
Q4 2021102$295.8M
Q3 2021119$375.3M
Q2 2021109$269.2M
Q1 202198$336.5M

Institutions, Q2 2025

Shares, value and share of portfolio for each institution holding Altimmune, Inc.; share changes are against Q1 2025.

Institutions holding ALT in Q2 2025
InstitutionSharesValue% of portfolioChange in sharesAction
KLP Kapitalforvaltning AS0$00.00%−11,300−100.0%Sold out
Sequoia Financial Advisors, LLC0$00.00%−10,155−100.0%Sold out
Headland Capital, LLC0$00.00%−10,097−100.0%Sold out
Cullen/Frost Bankers, Inc.0$00.00%−10,000−100.0%Sold out
Magnus Financial Group LLC0$00.00%−10,000−100.0%Sold out
Great West Life Assurance Co0$00.00%−4,354−100.0%Sold out
Amundi0$00.00%−3,273−100.0%Sold out
Penserra Capital Management LLC0$00.00%−1,587−100.0%Sold out
Public Employees Retirement Association of Colorado0$00.00%−552−100.0%Sold out
Medallion Wealth Advisors, LLC0$00.00%−435−100.0%Sold out
Optiver Holding B.V.0$00.00%−247−100.0%Sold out
Massmutual Trust Co FSB0$00.00%−240−100.0%Sold out
Aventura Private Wealth, LLC0$00.00%−200−100.0%Sold out
Stephens Consulting, LLC0$00.00%−65−100.0%Sold out
Lindbrook Capital, LLC––––Not filed